THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY EIGHTEENTH ANNUAL REPORT 1984 – 2013 ANZCOTR 2013.

Slides:



Advertisements
Similar presentations
HEART TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
Advertisements

HEART TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:
J Heart Lung Transplant 2009;28: HEART TRANSPLANTATION Pediatric Recipients ISHLT 2009.
HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
HEART TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
Concentric Circle Liver Distribution Models
ORGAN DONATION “My soul can find no staircase to heaven unless it is through earth's loveliness” -Michelangelo-
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
CHAPTER 3 HEART AND LUNG TRANSPLANTATION Editors: Mr Mohamed Ezani Md. Taib Dato’ Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
HEART TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
Optimizing lung transplant outcomes in the adult and pediatric patient. Cynthia S. Herrington, MD Associate Professor of Surgery Keck School of Medicine.
HEART-LUNG TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
Table SA-1: Number of Kidney Transplants by Donor Type and Re-Transplant Status Source: Canadian Organ Replacement Register, 2014, CIHI *Missing data for.
Canadian Organ Replacement Register (CORR) Preliminary Statistics on Organ Donation, Transplantation and Waiting List: 2005 CORR Preliminary Report Dr.
© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,
A Mission to Save More Lives Where we’ve been, where we are, and where we need to be Thomas A. Nakagawa, M.D, FAAP, FCCM Professor, Anesthesiology and.
End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report Chapter 12.
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
Predicting Major Outcomes after MCSD Implant 1 Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
HEART TRANSPLANTATION Pediatric Recipients JHLT Oct; 32(10):
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
CREATED BY: SAM LANGSTON PIT-4 TH PERIOD Organ Donation.
CIBIS II Cardiac Insufficiency Bisoprolol Study
 Kidney  Pancreas  Liver  Heart 1954 by Murray/Harrison 1966 by Lillehei 1967 by Starzl 1968 by Barnard.
Heart Transplantation A Brief Summary by Nikolett Jakab.
HEART-LUNG TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
[Your organisation’s logo and name can be inserted here]
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
LUNG TRANSPLANTATION Adult Recipients 2014 JHLT Oct; 33(10):
Table 3.1.1: Stock and Flow of Heart Transplantation, Year New transplant patients Deaths
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
[Your organisation’s logo and name can be inserted here]
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths.
Table 3.1.1: Stock and Flow of Heart Transplantation, Year New transplant patients Deaths
HEART-LUNG TRANSPLANTATION Pediatric Recipients 2015 JHLT Oct; 34(10):
When Using SRTR Slides. SRTR Slide Use Guidelines.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
The Registry of the International Society for Heart and Lung Transplantation: Thirty- second Official Adult Lung and Heart-Lung Transplantation Report—2015;
THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY
Total Artificial Heart (TAH): Survival Outcomes, Risk Factors,
Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,
The Registry of the International Society for Heart and Lung Transplantation: Twenty- seventh official adult heart transplant report—2010  Josef Stehlik,
Table 3.1.1a: Stock and Flow of Heart Transplantation,
Surgery for Ebstein’s Anomaly:
Copyright © 2017 American Academy of Pediatrics.
The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Official Adult Heart Transplant Report—2014; Focus Theme: Retransplantation 
Liver only transplants in the UK Question 2: In terms of survival benefit.
HEART-LUNG TRANSPLANTATION
HEART TRANSPLANTATION
HEART TRANSPLANTATION
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
HEART-LUNG TRANSPLANTATION
UK Renal Registry 13th Annual Report
THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY
HEART-LUNG TRANSPLANTATION
HEART-LUNG TRANSPLANTATION
Steven J. Chadban, Natalie D. Staplin  Kidney International 
Graphs from annual report 2018
Trends in the Indications and Survival in Pediatric Heart Transplants: A 24-year Single- Center Experience in 307 Patients  Rochus K. Voeller, MD, Deirdre.
Jerry D. Estep et al. JCHF 2013;1:
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
HEART-LUNG TRANSPLANTATION
A: Comparison of pediatric lung transplant survival between different age groups. A: Comparison of pediatric lung transplant survival between different.
HEART-LUNG TRANSPLANTATION
Presentation transcript:

THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY EIGHTEENTH ANNUAL REPORT 1984 – 2013 ANZCOTR 2013

NUMBER OF ALL TRANSPLANT TYPES BY YEAR ANZCOTR 2013

NUMBER OF ALL TRANSPLANTS* ANZCOTR 2013 *Includes domino, heterotopic and retransplants

ALL HEART TRANSPLANTS BY HOSPITAL

HEART LUNG TRANSPLANTS BY HOSPITAL ANZCOTR 2013 Prince Charles 2005 figure includes one retransplant

SINGLE LUNG TRANSPLANTS BY HOSPITAL ANZCOTR 2013

BILATERAL LUNG TRANSPLANTS BY HOSPITAL ANZCOTR 2013 Includes retransplants

COMBINED WAITING LIST ACTIVITY 2013 ANZCOTR 2013 *Contains complete calendar year activity from all Registry Participant Centres. nb lungs column includes heart/lung procedures HEARTS TOTALLUNGS TOTAL Active as at 1 January New Additions during From on hold to Active Jan 2013 Removals from Waiting List (Permanent) W1 - Transplant Performed86188 W2 - Patients condition Improved52 W3 - Too ill, new dev of contraindications etc1210 W4 - Patient declined11 W5 - Transferred to another interstate list10 W6 - Died waiting1514 W7-Removed - unspecified 01 TOTAL at Year end - (Active) 31 December Total at month end inactive - (On HOLD)910

PRE TRANSPLANT DIAGNOSIS HEART ISCHAEMIC HEART DISEASE 34% IDIOPATHIC DILATED CARDIOMYOPATHY 40% Viral CM / Myocarditis 3% Congenital HD 6% Other 13% Retransplant 1% Peripartum CM 1% ANZCOTR 2013 Familial CM 2%

PRE TRANSPLANT DIAGNOSIS n = 2384 ANZCOTR 2013

PRE-TRANSPLANT STATUS HEARTS ANZCOTR 2013

PRE-TRANSPLANT STATUS HEARTS ANZCOTR 2013 STATUS - Year n= NYHA III % NYHA IV % Inotropic support % Intra-aortic Balloon Pump % Ventricular Assist Device % Total Artificial Heart %

DONOR / RECIPIENT STATE OF ORIGIN HEARTS Number ANZCOTR 2013

DONOR / RECIPIENT STATE OF ORIGIN HEARTS ANZCOTR 2013

Mean Waiting Time to Transplant HEARTS DAYS YEAR ANZCOTR 2013

WAITING DAYS TO HEART TRANSPLANT ANZCOTR 2013

Mean Recipient Age at Transplant HEARTS Year Age(yrs) ANZCOTR 2013

RECIPIENT AGE AT HEART TRANSPLANT YEARS ANZCOTR 2013

Hearts Mean Donor Age Year Age in years ANZCOTR 2013

DONOR AGE HEARTS - YEARS ANZCOTR 2013

HEARTS - Mean Ischaemic Time Minutes Year ANZCOTR 2013

MEAN HEART ISCHAEMIC TIME - MINUTES ANZCOTR 2013

ACTUARIAL SURVIVAL - HEART TRANSPLANT n* = Number alive at start of year ANZCOTR 2013

ACTUARIAL SURVIVAL - HEART TRANSPLANT Percent Survival YEAR ANZCOTR 2013 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL – ORTHOTOPIC v HETEROTOPIC v DOMINO TRANSPLANTS ANZCOTR 2013

Actuarial Survival Orthotopic v Heterotopic v Domino Hearts Percent Survival ANZCOTR 2013 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL ALL HEARTS PERIOD COMPARISON 1984 – 2013 ANZCOTR 2013 Percent Survival p<0.001 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL HEARTS PERIOD COMPARISON ANZCOTR 2013 *N = NUMBER ALIVE AT START OF YEAR

ACTUARIAL SURVIVAL PRE TRANSPLANT DIAGNOSIS Percent ANZCOTR 2013 IDCM v IHD p<0.005 IHD v Others p<0.005 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL PRE TRANSPLANT DIAGNOSIS HEARTS 1984 – 2013 ANZCOTR 2013

ACTUARIAL SURVIVAL PRE-TRANSPLANT STATUS HEARTS ANZCOTR 2013 Percent Survival Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel p=ns

ACTUARIAL SURVIVAL PRE-TRANSPLANT STATUS HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL RECIPIENT AGE BY GENDER HEARTS ANZCOTR 2013 *N= NUMBER ALIVE AT START OF YEAR

ACTUARIAL SURVIVAL BY RECIPIENT AGE AND GENDER HEARTS ANZCOTR 2013 Percent Survival MALES 0-39 yrsv MALES>39yrs p<0.005 MALES>39yrs v FEMALES>39yrs p <0.05 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL DONOR AGE HEARTS ANZCOTR 2013 * * 2 OF THE 16 CASES IN THE GREATER THAN 59 YEARS CATEGORY ARE HETEROTOPIC HEART TRANSPLANTS

ACTUARIAL SURVIVAL DONOR AGE HEARTS YEAR Percent Survival ANZCOTR OF THE 11 CASES IN THE GREATER THAN 59 YEARS CATEGORY ARE HETEROTOPIC HEART TRANSPLANTS Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel 0-16yrs v 40-49yrs p< yrs v 50-59yrs p< yrs v 40-49yrs p< yrs v 50-59yrs p<0.009

ACTUARIAL SURVIVAL DONOR GENDER HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL DONOR GENDER HEARTS Year Percent Survival ANZCOTR 2013 p=ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL RECIPIENT GENDER HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL RECIPIENT GENDER HEARTS Year Percent Survival ANZCOTR 2013 p=ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL ISCHAEMIC TIME HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL ISCHAEMIC TIME HEARTS ANZCOTR 2013 p=ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL CROSSMATCH HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL CROSSMATCH HEARTS Year Percent Survival ANZCOTR 2013 p < 0.01 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL PEAK PANEL REACTIVE ANTIBODIES ALL HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL PEAK PRA ALL HEARTS Year Percent Survival ANZCOTR 2013 p=ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL CMV STATUS HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL CMV STATUS HEARTS Year Percent Survival ANZCOTR 2013 p=ns R+ve = R+veD+ve or R+veD-ve Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL HLA MISMATCH HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL HLA MISMATCH HEARTS Year Percent Survival ANZCOTR 2013 p<0.05 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL HLA DR LOCUS MISMATCH HEARTS ANZCOTR 2013

ACTUARIAL SURVIVAL HLA DR LOCUS MISMATCH HEARTS Year Percent Survival ANZCOTR 2013 p= ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL MALIGNANCIES HEART ANZCOTR 2013 *Survival of the group who were defined by having developed a malignancy

ACTUARIAL SURVIVAL MALIGNANCIES HEARTS Year Percent Survival ANZCOTR 2013 ptld v other mal p=<0.005 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

RECIPIENT CAUSE OF DEATH - HEARTS n = 1114 TxCADMisc InfectionAcute Rejection Other Malignancies PTLDCVAHemorrhage No of Deaths ANZCOTR % 27% 14% 10% 15% 4% 1% NSGF 7%

CAUSE OF DEATH HEARTS ANZCOTR 2013

CAUSE OF DEATH ALL HEARTS <5 YEARS AFTER TX ANZCOTR 2013 No% Infection10822 Misc (incl 4 no data8717 Rejection8617 Non Specific Graft Failure6714 Graft Atherosclerosis (TxCAD)5611 Non Lymphoid Malignancy306 Lymphoproliferative Disease133 CVA204 Haemorrhage122 Graft Atherosclerosis & Rejection92 Pulmonary Failure61 Pulmonary Hypertension21 Totals

CAUSE OF DEATH ALL HEARTS ≥5 YEARS AFTER TX No % Misc (incl data pending)17829 Graft Atherosclerosis (TxCAD)14523 Non Lymphoid Malignancy14123 Infection457 Lymphoproliferative Disease325 Rejection203 CVA224 Non Specific Graft Failure163 Pulmonary Failure61 Haemorrhage30.5 Graft Atherosclerosis & Rejection71 Pulmonary Hypertension10.5 Totals ANZCOTR 2013

MALIGNANCIES* - HEART n = PTLD 16 % Other 84 % ANZCOTR 2013 *the count of initial diagnosis only

MALIGNANCIES - HEART N= ANZCOTR 2013

Reason for Transplant Heart Lung PPH 26% Eisenmenger’s 21% Other PH 3% AAT deficiency 7% Emphysema 3% Congenital Heart Disease 14% Cystic Fibrosis 14% CFA 3% Bronchiectasis 2% Misc 7% ANZCOTR 2013

REASON FOR TRANSPLANT HEART LUNG n = ANZCOTR 2013 Primary Pulmonary Hypertension 47 Eisenmenger's Syndrome 37 Congenital Heart Disease 26 Cystic Fibrosis 25 Alpha-1-Antitrypsin Deficiency 13 Emphysema 6 Cryptogenic Fibrosing Alveolitis 5 Other Pulmonary Hypertension 6 Bronchiectasis 4 Miscellaneous 13 Total 182

Reason for Transplant Single Lung AAT 16% Emphysema 51% IPF 25% Misc 6% Bronchiectasis 1% Other PH / Eisenmengers / CF 1% ANZCOTR 2013

REASON FOR TRANSPLANT SINGLE LUNG n = 476 ANZCOTR 2013

Reason for Transplant Bilateral Lung 1992 – 2013 n =1704 Cystic Fibrosis 33% Emphysema 27% IPF 10% Bronchiectasis 8% Misc 9% AAT 7% Other PH 1% PPH 4% ANZCOTR 2013 Eisenmengers 1%

REASON FOR TRANSPLANT BILATERAL LUNG n = 1704 ANZCOTR 2013

Donor / Recipient State of Origin All Lungs ANZCOTR 2013 Number *Retransplants and unknown state of origins are not included

DONOR / RECIPIENT STATE OF ORIGIN ALL LUNGS ANZCOTR 2013 *Retransplants and unknown state of origins are not included

Mean Wait to Transplant All Lungs Days Year ANZCOTR 2013

MEAN WAITING TIME TO LUNG TRANSPLANT – DAYS ANZCOTR 2013

Mean Recipient Age at Transplant LUNGS ANZCOTR 2013 Age in Years

MEAN RECIPIENT AGE AT LUNG TRANSPLANT ANZCOTR 2013

Mean Donor Age at Transplant ALL LUNGS ANZCOTR 2013 Years of Age

MEAN DONOR AGE AT TRANSPLANT LUNGS ANZCOTR 2013

LUNGS MEAN ISCHAEMIC TIME ANZCOTR 2013 Minutes

LUNGS - MEAN ISCHAEMIC TIME MINUTES ANZCOTR 2013

Recipient Gender % Lung Transplants % ANZCOTR 2013

Recipient Gender Lung Transplants ANZCOTR 2013

ACTUARIAL SURVIVAL ALL LUNGS ANZCOTR 2013

ACTUARIAL SURVIVAL ALL LUNG TRANSPLANTS Year Percent Survival ANZCOTR 2013 SL v HL p<0.005 SL v BL p<0.005 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL DCD DONORS V DBD DONORS Year Percent Survival ANZCOTR 2013 p=ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL DCD DONORS v DBD DONORS ANZCOTR 2013

ACTUARIAL SURVIVAL DONOR AGE ALL LUNGS YEAR Percent Survival ANZCOTR yrs vs 40-49yrs p< yrs vs 40-49yrs p<0.05 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL DONOR AGE ALL LUNGS 1986 – 2013 ANZCOTR 2013

ACTUARIAL SURVIVAL ISCHAEMIC TIME ALL LUNGS ANZCOTR 2013

ACTUARIAL SURVIVAL ISCHAEMIC TIME ALL LUNGS Year Percent Survival ANZCOTR 2013 p=ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL CROSSMATCH ALL LUNGS ANZCOTR 2013

ACTUARIAL SURVIVAL CROSSMATCH LUNGS Year Percent Survival ANZCOTR 2013 p=ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL CMV STATUS ALL LUNGS ANZCOTR 2013

ACTUARIAL SURVIVAL CMV STATUS LUNGS ANZCOTR 2013 Percent Survival Years R-D+ vs R+ p<0.05 R+ve = R+ve/D+ve or R+ve/D-ve Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL HLA MISMATCH ALL LUNGS ANZCOTR 2013

ACTUARIAL SURVIVAL HLA MISMATCH ALL LUNGS 1986 – 2013 ANZCOTR 2013 Years Percent Survival MM0-1 v MM5 p<0.05 MM0-1 v MM6 p<0.05 Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL HLA DR LOCUS MISMATCH ALL LUNGS ANZCOTR 2013 Percent Survival Years p=ns Survival by Cutler-Ederer life tables, comparisons by log rank Cox-Mantel

ACTUARIAL SURVIVAL HLA DR LOCUS MISMATCH LUNGS 1986 – 2013 ANZCOTR 2013

CAUSE OF DEATH - ALL LUNGS ANZCOTR 2012

CAUSE OF DEATH - LUNGS n = 1219 ANZCOTR 2013

CAUSE OF DEATH ALL LUNGS < 5 YEARS POST TX CAUSE OF DEATH ALL LUNGS ≥ 5 YEARS POST TX ANZCOTR 2013